SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001325
Filing Date
2020-02-25
Accepted
2020-02-25 16:32:03
Documents
106
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K acrs-20191231x10k.htm 10-K 3808878
2 EX-4.2 acrs-20191231ex42f1240e5.htm EX-4.2 28114
3 EX-10.14 acrs-20191231ex101456d79.htm EX-10.14 18326
4 EX-10.15 acrs-20191231ex10157228e.htm EX-10.15 18436
5 EX-10.20 acrs-20191231ex10208578b.htm EX-10.20 140344
6 EX-21.1 acrs-20191231ex2114a983e.htm EX-21.1 8340
7 EX-23.1 acrs-20191231ex2310737a9.htm EX-23.1 4277
8 EX-31.1 acrs-20191231ex3119e3c71.htm EX-31.1 10933
9 EX-31.2 acrs-20191231ex312c0ce79.htm EX-31.2 9931
10 EX-32.1 acrs-20191231ex321b503ff.htm EX-32.1 12455
11 GRAPHIC acrs20191231x10k001.jpg GRAPHIC 95149
  Complete submission text file 0001558370-20-001325.txt   14096028

Data Files

Seq Description Document Type Size
12 EX-101.INS acrs-20191231.xml EX-101.INS 3222023
13 EX-101.SCH acrs-20191231.xsd EX-101.SCH 76463
14 EX-101.CAL acrs-20191231_cal.xml EX-101.CAL 105371
15 EX-101.DEF acrs-20191231_def.xml EX-101.DEF 296616
16 EX-101.LAB acrs-20191231_lab.xml EX-101.LAB 783093
17 EX-101.PRE acrs-20191231_pre.xml EX-101.PRE 555823
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37581 | Film No.: 20651149
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences